Weekend Story: Coming Soon CBD Medication For Your Anxious Dog

Canopy Growth Corporation (TSX: WEED) (NYSE: CGC) and its wholly owned subsidiary Canopy Health Innovations Inc. has announced this morning that they been approved by the Veterinary Drug Directorate of Health Canada to research the effectiveness of the non-psychoactive cannabinoid cannabidiol (“CBD”) to treat anxiety in pets.


Go to Source

Powered by WPeMatico